WallStSmart

Amrize Ltd (AMRZ)vsKnife River Corporation (KNF)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Amrize Ltd generates 268% more annual revenue ($12.18B vs $3.31B). AMRZ leads profitability with a 10.1% profit margin vs 4.2%. AMRZ appears more attractively valued with a PEG of 1.44. AMRZ earns a higher WallStSmart Score of 65/100 (B-).

AMRZ

Strong Buy

65

out of 100

Grade: B-

Growth: 5.3Profit: 6.5Value: 5.7Quality: 5.0
Piotroski: 2/9Altman Z: 1.61

KNF

Buy

54

out of 100

Grade: C-

Growth: 4.7Profit: 5.5Value: 4.0Quality: 5.5
Piotroski: 1/9Altman Z: 2.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AMRZ.

KNFSignificantly Overvalued (-88.1%)

Margin of Safety

-88.1%

Fair Value

$42.85

Current Price

$57.55

$14.70 premium

UndervaluedFair: $42.85Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.5%8/10

Strong operational efficiency at 20.5%

KNF1 strengths · Avg: 8.0/10
Price/BookValuation
2.0x8/10

Reasonable price relative to book value

Areas to Watch

AMRZ2 concerns · Avg: 3.5/10
Altman Z-ScoreHealth
1.614/10

Distress zone — elevated risk

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

KNF4 concerns · Avg: 3.3/10
PEG RatioValuation
1.624/10

Expensive relative to growth rate

Profit MarginProfitability
4.2%3/10

4.2% margin — thin

Debt/EquityHealth
1.043/10

Elevated debt levels

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Operating Margin. PEG of 1.44 suggests the stock is reasonably priced for its growth.

Bull Case : KNF

The strongest argument for KNF centers on Price/Book. Revenue growth of 12.6% demonstrates continued momentum.

Bear Case : AMRZ

The primary concerns for AMRZ are Altman Z-Score, Piotroski F-Score.

Bear Case : KNF

The primary concerns for KNF are PEG Ratio, Profit Margin, Debt/Equity. Thin 4.2% margins leave little buffer for downturns.

Key Dynamics to Monitor

KNF is growing revenue faster at 12.6% — sustainability is the question.

AMRZ generates stronger free cash flow (173M), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

AMRZ scores higher overall (65/100 vs 54/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology firm at the forefront of the digital health and wellness industry, dedicated to transforming healthcare delivery with cutting-edge technologies and data-driven solutions. The company prioritizes enhancing patient outcomes and access to care, significantly investing in research and development to address the rising demand for scalable health innovations. With a diverse portfolio of products and strategic initiatives, Amrize is well-positioned to become a critical player in the ongoing evolution of healthcare, presenting a compelling investment opportunity for institutional investors navigating a dynamic market.

Visit Website →

Knife River Corporation

BASIC MATERIALS · BUILDING MATERIALS · USA

Knife River Corporation provides aggregates-based construction materials and contracting services in the United States. The company is headquartered in Bismarck, North Dakota.

Want to dig deeper into these stocks?